{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:44:15Z","timestamp":1746711855658,"version":"3.40.5"},"reference-count":25,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>Oseltamivir prescribing among pediatric inpatients with influenza varied from 2% to 48% prior to the 2009 H1N1 pandemic. After the pandemic, prescribing guidelines were expanded, and studies reported benefits for hospitalized children. Post-pandemic prescribing practices among children are unclear.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVES:<\/jats:title>\n                  <jats:p>To report the rate of oseltamivir use and to identify factors associated with its use among inpatients with confirmed influenza infection from 2010 to 2014 at a tertiary children\u2019s hospital.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study of inpatients with polymerase chain reaction\u2013confirmed influenza from December 2010 to April 2014 at Children\u2019s Hospital Colorado. The primary outcome was oseltamivir use. Variables regarding demographics, underlying medical conditions, diagnoses, and hospital course were also explored. Univariate and multivariate logistic regression analyses were performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Among 395 inpatients with influenza, 323 (82%) received oseltamivir. In univariate analyses, oseltamivir use was associated with admission within 48 hours of symptom onset (89% vs 77%), ICU admission (88% vs 79%), longer length of stay (90% for &amp;gt;6 days vs 77% for \u22642 days), and influenza A H1N1 infection (P &amp;lt; .05 for all). In multivariate logistic regression analysis, longer length of stay, illness during the 2013\u20132014 season, and admission within 48 hours of symptom onset were associated with higher odds of oseltamivir use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Oseltamivir use for children with influenza in the postpandemic era is increasing at our institution, aligning with official recommendations and reported benefits. We report highest use for patients in the 2013\u20132014 season, those who present early in their illness, and those requiring a prolonged hospital stay.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2015-0126","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T09:24:04Z","timestamp":1456824244000},"page":"172-178","source":"Crossref","is-referenced-by-count":6,"title":["Rising Oseltamivir Use Among Hospitalized Children in a Postpandemic Era"],"prefix":"10.1542","volume":"6","author":[{"given":"Joshua T.B.","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora, Colorado; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen A.","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (Hospital Medicine and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen M.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics (Hospital Medicine and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchitra","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora, Colorado; and"},{"name":"Department of Pediatrics (Hospital Medicine and"},{"name":"Infectious Diseases), University of Colorado School of Medicine and Children\u2019s Hospital Colorado, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"2021120817451661200_B1","unstructured":"Tamiflu (oseltamivir phosphate) capsules and for oral suspension. NDA 21-087\/S-016.\u00ee US Food and Drug Administration. December, 2007. Available at: http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2004\/021087_S016_021246s010TamifluTOC.cfm. (Accessed December 12 2014)"},{"issue":"4","key":"2021120817451661200_B2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1542\/peds.2007-0224","article-title":"Antiviral therapy and prophylaxis for influenza in children","volume":"119","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"2021120817451661200_B3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jhm.431","article-title":"Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder","volume":"4","author":"Wilkes","year":"2009","journal-title":"J Hosp Med"},{"issue":"5","key":"2021120817451661200_B4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.inf.0000214988.81379.71","article-title":"Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003\u20132004","volume":"25","author":"Schrag","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2021120817451661200_B5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1542\/peds.2012-1255","article-title":"The burden of influenza in young children, 2004\u20132009","volume":"131","author":"Poehling","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"2021120817451661200_B6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2010.05.012","article-title":"Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008","volume":"157","author":"Dawood","year":"2010","journal-title":"J Pediatr"},{"issue":"10","key":"2021120817451661200_B7","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/INF.0b013e3182214e28","article-title":"Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic","volume":"30","author":"Hersh","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2021120817451661200_B8","doi-asserted-by":"crossref","first-page":"e15173","DOI":"10.1371\/journal.pone.0015173","article-title":"Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU","volume":"5","author":"Bagdure","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"2021120817451661200_B9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-2149","article-title":"Neuraminidase inhibitors for critically ill children with influenza","volume":"132","author":"Louie","year":"2013","journal-title":"Pediatrics"},{"issue":"3","key":"2021120817451661200_B10","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/cis442","article-title":"Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic","volume":"55","author":"Garg","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"17","key":"2021120817451661200_B11","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1001\/jama.2009.1496","article-title":"Critically ill patients with 2009 influenza A(H1N1) infection in Canada","volume":"302","author":"Kumar","year":"2009","journal-title":"JAMA"},{"issue":"11","key":"2021120817451661200_B12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/INF.0b013e318232ede9","article-title":"Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study","volume":"30","author":"Coffin","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"2021120817451661200_B13","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/INF.0b013e3182093397","article-title":"2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease","volume":"30","author":"Launes","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"2021120817451661200_B14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/PCC.0b013e318260114e","article-title":"Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A","volume":"13","author":"Eriksson","year":"2012","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"2021120817451661200_B15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00134-010-1853-1","article-title":"Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina","volume":"36","author":"Farias","year":"2010","journal-title":"Intensive Care Med"},{"issue":"11","key":"2021120817451661200_B16","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archpediatrics.2010.203","article-title":"Children hospitalized with 2009 novel influenza A(H1N1) in California","volume":"164","author":"Louie","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"first-page":"447","year":"2012","author":"Pickering","key":"2021120817451661200_B17"},{"issue":"2","key":"2021120817451661200_B18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"4","key":"2021120817451661200_B19","article-title":"Recommendations for prevention and control of influenza in children, 2013\u20132014","volume":"132","author":"American Academy of Pediatrics, Committee on infectious diseases","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"2021120817451661200_B20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1542\/peds.2010-2216","article-title":"Policy statement\u2014recommendations for prevention and control of influenza in children, 2010\u20132011","volume":"126","author":"American Academy of Pediatrics, Committee on Infectious Diseases","year":"2010","journal-title":"Pediatrics"},{"key":"2021120817451661200_B21","doi-asserted-by":"crossref","first-page":"f7148","DOI":"10.1136\/bmj.f7148","article-title":"Methodological concerns about studies on oseltamivir for flu","volume":"347","author":"Ebell","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"2021120817451661200_B22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/fampra\/cms059","article-title":"Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials","volume":"30","author":"Ebell","year":"2013","journal-title":"Fam Pract"},{"key":"2021120817451661200_B23","first-page":"CD008965","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children","volume":"4","author":"Jefferson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2021120817451661200_B24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/498517","article-title":"Effects of local variation, specialty, and beliefs on antiviral prescribing for influenza","volume":"42","author":"Rothberg","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2021120817451661200_B25","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/INF.0000000000000321","article-title":"The burden of influenza hospitalizations in infants from 2003 to 2012, United States","volume":"33","author":"Chaves","year":"2014","journal-title":"Pediatr Infect Dis J"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/6\/3\/172\/812939\/hpeds_2015-0126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/6\/3\/172\/812939\/hpeds_2015-0126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T19:04:21Z","timestamp":1638990261000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/6\/3\/172\/26324\/Rising-Oseltamivir-Use-Among-Hospitalized-Children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,1]]},"published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2015-0126","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"type":"print","value":"2154-1663"},{"type":"electronic","value":"2154-1671"}],"subject":[],"published":{"date-parts":[[2016,3,1]]}}}